🟢 Intellia Therapeutics is trading 6.3% up in after-hours trading with no confirmed catalyst

Intellia Therapeutics is trading 6.3% up at $13.38 in an unexplained after-hours rebound, with no confirmed catalyst.

• The stock closed at $12.58 on October 12, down 3.75% for the regular session.
• No verified October 12 company announcement directly explained the move. Recent coverage focused on safety concerns and paused Phase 3 trials, while market reporting described mixed, nearly flat trading; neither established a cause for the rebound.